Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances

Vanda Pharmaceuticals

Status: Enrolling

Conditions: Sleep Disturbances in Smith-Magenis Syndrome

Treatments: Other: Data collection of sleep disturbances in individuals with SMS

Study type: Observational

Funder types: Industry

Identifiers

NCT03154697

Pro00015678

Details and patient eligibility

About

This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 3 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Parent or legal guardian of individual with Smith-Magenis Syndrome

Exclusion criteria

• Not legal guardian of individual with SMS